In situ analyses of genome instability in breast cancer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An analysis of genome instability and other features associated with telomere crisis, including anaphase and chromatin bridges, suggests that transition through telomere crisis in breast cancer occurs during progression from usual ductal hyperplasia (UDH) to ductal carcinoma in situ (DCIS)145.”
From Telomeres in cancer: tumour suppression and genome instability (2017) · cites this paper as [145]
In the citing paper
“Short telomeres and a sharp increase in genome instability are observed in the early stages of breast cancer before telomerase activation and genome stabilization [353].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [353]
In the citing paper
“telomeres were shown to be shorter in invasive cancers Telomeres and telomerase in cancer of the breast, prostate and pancreas, as well as in their pre-invasive counterparts (123-126).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [124]
In the citing paper
“Recent observations indicate that both telomere dysfunction73, 74 and the DDR75, 76 are activated at the earliest stages in many human carcinomas.”
From Telomere dysfunction and tumour suppression: the senescence connection (2008) · cites this paper as [73]
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Risk Factors for Breast Cancer in Women with Proliferative Breast Disease
Dupont, W. D., & Page, D. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120303 · Cited by 1,829 · cited 1×
“This may explain why the risk of developing invasive cancer in individuals with UDH is only modestly increase”
BackgroundTelomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice
Artandi, S. E., Chang, S., Lee, S.-L., Alson, S., Gottlieb, G. J., Chin, L., & DePinho, R. A. (2000) · Nature · doi:10.1038/35020592 · Cited by 1,085
Assembly of microarrays for genome-wide measurement of DNA copy number
Snijders, A. M., Nowak, N., Segraves, R., Blackwood, S., Brown, N., Conroy, J., Hamilton, G., Hindle, A. K., Huey, B., Kimura, K., et al. (2001) · Nature Genetics · doi:10.1038/ng754 · Cited by 999 · cited 1×
“We analyzed genome copy-number changes using array CGH as described previousl”
MethodSelf-citationRegulation of Telomerase by Telomeric Proteins
Smogorzewska, A., & de Lange, T. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.071403.160049 · Cited by 798 · cited 1×
“Most epithelial cells lack active telomerase, and so extended proliferation leads to telomere erosion and, eventually, loss of telomere functio”
BackgroundConnecting Chromosomes, Crisis, and Cancer
Maser, R. S., & DePinho, R. A. (2002) · Science · doi:10.1126/science.297.5581.565 · Cited by 561 · cited 1×
“The molecular events that enable normal epithelial cells to progress to invasive, metastatic disease are increasingly well understoo”
BackgroundNormal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes
Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., & Tlsty, T. D. (2001) · Nature · doi:10.1038/35054579 · Cited by 560
Self-citationERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization
Kallioniemi, O. P., Kallioniemi, A., Kurisu, W., Thor, A., Chen, L. C., Smith, H. S., Waldman, F. M., Pinkel, D., & Gray, J. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5321 · Cited by 555
Self-citationTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“and are almost always eliminated by damage-surveillance mechanism”
Background
Cited by
Items 301–361 of 361
Wang, Q., Sun, X., Han, X., Zhang, X., Wang, W., Wang, H., Ren, H., & Gu, L. (2026) · MedComm – Oncology · doi:10.1002/mog2.70054 · Cited by 2
George, A. M., Chen, Y., Gladchuk, S., Alcaide, M., Dalal, H., Meng, P., Brueffer, C., Saghir, H., Kimbung, S., Aaltonen, K. E., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00447-z · Cited by 1
“For example, it is understood that many SVs form early in tumorigenesis during the ‘ telomere crisis ’ , the period when rapidly dividing pre-malignant cells experience telomere shortening that leads to chromosome end fusions, double-strand breakage, and erroneous repair (Chin et al, 2004).”
ZNF217 (zinc finger protein 217)
Yaswen, P., & Collins, C. C. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38264 · Cited by 1
Self-citationTelomere Shortening and Telomerase Activation during Cancer Formation
Rudolph, K. L. (2007) · Springer eBooks · doi:10.1007/978-3-540-73709-4_11 · Cited by 1
Studying Interrelation of PDLIM4 with the Model of CD74-Mediated Development of Breast Cancer
Kravchenko, D. S., Lezhnin, Y. N., Ivanova, A. E., Kravchenko, Y. E., & Frolova, E. I. (2017) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2017.50.57 · Cited by 1
“Previous studies of PDLIM4 expression showed that different breast cancer tumors are characterized by high polymorphism in the intracellular level of this protein Neve, Chin et al. (2004).”
BackgroundDelivery of Natural Products Using Polymeric Particles for Cancer Chemotherapeutics
Ahuja, R., Panwar, N., Meena, J., Sarkar, D. P., & Panda, A. K. (2020) · Sustainable agriculture reviews · doi:10.1007/978-3-030-41838-0_3 · Cited by 1
Local Pattern Discovery in Array-CGH Data
Rouveirol, C., & Radvanyi, F. (2005) · Lecture notes in computer science · doi:10.1007/11504245_9 · Cited by 1
Telomere biology: Implications for radiation carcinogenesis
Kodama, S., Ariyoshi, K., Watanabe, S., Shiraishi, K., & Watanabe, M. (2007) · International Congress Series · doi:10.1016/j.ics.2006.10.010 · Cited by 1
Monitoring Chromosome Rearrangements
Speicher, M. R. (2006) · Springer eBooks · doi:10.1007/1-4020-3764-3_2 · Cited by 1
Decoding human liver cancer signatures.
Lee, J. (2008) · PubMed Central · Cited by 1
Friedenson, B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.08.467751 · Cited by 1
“This scenario occurs in EBV-positive Burkitt lymphomas (Kamranvar et al, 2007; Lacoste et al, 2010) and produces visible anaphase bridges in precursor forms of breast cancer (Chin et al, 2004).”
BackgroundTelomere Dysfunction And Chromosomal Instability In Hodgkin Lymphoma
Cuceu, C. (2015) · theses.fr (ABES) · doi:10.70675/70e0fcb6zb34az4277za148z4b8443d78366 · Cited by 1
Pharmacogenomic Approach of Telomerase in Cancer: Importance of End Zone Variability
Catarino, R., Nogueira, A., Coelho, A., & Medeiros, R. (2011) · InTech eBooks · doi:10.5772/24608
Decoding the Liver Cancer Genome
Lee, J., & Thorgeirsson, S. S. (2009) · Wiley eBooks · doi:10.1002/9780470747919.ch60
Telomere Maintenance Mechanisms in Soft Tissue Sarcomas
Matthew, J., & Broccoli, D. (2011) · InTech eBooks · doi:10.5772/26996
“generating a hypermutability environment (Chin et al., 2004), analogous to the tumorigenic”
BackgroundZwang, Y. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada581164
Chromosomal alterations and telomere dysfunction in breast tumours
Böðvarsdóttir, S. K. (2008) · Skemman
Genetische Veränderungen des sporadischen Mammakarzinoms
Arnold, N. (2006) · Springer eBooks · doi:10.1007/978-3-540-31748-7_16
Characterization and functional studies of PPM1D in breast cancer
Pärssinen, J. (2007) · Tampere University Institutional Repository (Tampere University)
de Paula, M. P. S. A. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2012.tde-18042013-102717 · Cited by 1
“Isto gera mutações que promovem o tumor e a subsequente ativação da telomerase estabiliza o genoma mutante e confere a capacidade ilimitada de replicação (CHIN et al., 2004; RAYNAUD et al., 2010).”
BackgroundStructure and Function of the Telomere
Johnson, J. E., & Broccoli, D. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_7
“system to model the role of telomere dysfunction on both genomic instability and tumor progression ( 110 ).”
BackgroundTelomeres and Telomerase in Adrenocortical Carcinoma
Else, T., & Hornsby, P. J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77236-3_13
“Recent studies have focused on breast cancer and colon cancer [63–66].”
BackgroundInfluentialLockett, S. J., Ortíz-de-Solórzano, C., Baggett, D., & Chin, K. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1408-6
Self-citationUp a gear? The significance of an elevated mutation rate in tumorigenesis
Page, K. M. (2007) · Physics of Life Reviews · doi:10.1016/j.plrev.2007.04.001
“With renewed telomere maintenance, the genomic instability of these cancer cells is reduced, although they will retain unusual karyotypes [21].”
BackgroundAn oncogene-induced DNA replication stress model for human cancer development
Halazonetis, T. D., Zgheib, O., Gorgoulis, V. G., & Bártek, J. (2008) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(08)71417-4 · Cited by 1
Assessment of therapeutic targets in experimental models of Myc-induced lymphoma
Forshell, L. P. (2011)
Moreira, D. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2012.tde-24052012-085615 · Cited by 2
Mercier, N. (2015) · EspaceINRS (National Institute for Scientific Research (Canada))
May, B. (2015) · UWSpace (University of Waterloo)
Suppression of mammary tumorigenesis by a Gemini vitamin D analog and a synthetic truterpenoid
So, J. Y. (2013) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t3jw8ck7
“However, along the progression from DCIS to IDC, most of genetic or molecular alterations are already present at DCIS stage [291,292].”
BackgroundÅlgars, A. (2012) · UTUPub (University of Turku)
Understanding and Using Information about Cancer Genomes
Spellman, P. T., Stuart, J. M., & Gray, J. W. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4066-6.00024-x
Self-citationEarly Biomarkers in Breast Cancer
Kaul-Ghanekar, R., Suryavanshi, S., & Raina, P. (2015) · CRC Press eBooks · doi:10.1201/b18015-6
Early Biomarkers in Breast Cancer
Raina, P. (2013) · CRC Press eBooks · doi:10.1201/b16389-28
Causes and consequences of genomic instability in prostatic carcinogenesis.
Joshua, A. M. (2009) · TSpace (University of Toronto)
Array-CGH in pediatric neurology: A prospective observational study
Vitaliti, G., Pavone, P., Motamed-Gorji, N., Matin, N., Vecchio, M. M., Ledda, C., Lubrano, R., & Falsaperla, R. (2016) · European Journal of Inflammation · doi:10.1177/1721727x16677605
“14(3) 196 –199 © The Author(s) 2016 Reprints and permissions: sagepub.”
Nanotechnology-based Strategies To Enhance Chemo-and Radiation Therapy In Breast Cancer
Prasad, P. (2014) · TSpace (University of Toronto)
Spellman, P. T., Costello, J., & Gray, J. W. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10020-2
Self-citationMicroarray Profiling in Breast Cancer Patients
Qian, Y. R., Shi, X., Castranova, V., & Guo, N. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-088-5_16
“This technology is valuable in exploring genomic instability in breast cancer development and progression ( 15 ,16,17).”
BackgroundAn Oncogene-Induced DNA Replication Stress Model for Cancer Development
Halazonetis, T. D. (2009) · Springer eBooks · doi:10.1007/978-90-481-2561-6_3
Telomere maintenance and genome stability
Huang, W., Hernandez-Sanchez, W. M., Xu, M., & Taylor, D. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85679-9.00021-0
Faculty Opinions recommendation of Telomeres in cancer: tumour suppression and genome instability.
Savage, S. A. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727224887.793545187
Roylance, R. R., Endesfelder, D., Gorman, P. A., Burrell, R. A., Sander, J., Tomlinson, I. P. M., Hanby, A. M., Speirs, V., Richardson, A. L., Birkbak, N. J., et al. (2023) · doi:10.1158/1055-9965.c.6514830
DNA Replication Stress and Genome Instability in Breast Cancer
Sinha, K., Sang, P. B., Sharma, P., & Jaiswal, R. K. (2023) · Wiley eBooks · doi:10.1002/9783527841165.ch2
Multistage Carcinogenesis: Cell and Animal Models
Kulesz-Martin, M. F., Ouyang, X., Ramin, S., Barling, A. N., Gallegos, J. R., Liu, Y., & Medler, T. R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00085-1
The Role of Telomeres in Genomic Instability
Murnane, J. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-221-2_10 · Cited by 1
Wei, L., Tian, Z., Wang, Z.-Y., Liu, W., Li, H.-B., & Zhang, Y. (2025) · World Journal of Clinical Cases · doi:10.12998/wjcc.v13.i18.101882
Olsen, T. (2012) · NVA (Nasjonalt vitenarkiv) · Cited by 1
Nachmanson, D., Steward, J., Yao, H., Officer, A., Jeong, E., O’Keefe, T. J., Hasteh, F., Jepsen, K., Hirst, G. L., Esserman, L. J., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13257780
YAP1 Dysfunction Promotes Molecular Properties Linked to Breast Cancer Susceptibility
Fresques, T., Lopez, J. C., Hussey, D., Miyano, M., Garbe, J. C., Hinz, S., Sayaman, R. W., Li, A., Schmolze, D. B., Bedford, S. V., et al. (2025) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-25-0027 · Cited by 1
“These barriers were described in cultured HMEC and accurately model molecular features of early progression in vivo (15, 16).”
Self-citationAddou-Klouche, L. (2011) · theses.fr (ABES) · doi:10.70675/082349a1za09dz495fzacc4z6ad4775402d6 · Cited by 1
Differential Effects of the Cytokine Thymic Stromal Lymphopoietin on Human Dendritic Cell Subsets
Martínez-Cingolani, C. (2013) · theses.fr (ABES) · doi:10.70675/9eaddebczc13cz432fzbb03z3c19d6923f06
Salvador, M. A. (2014) · theses.fr (ABES) · doi:10.70675/e6271213z23d6z45e2z8558z016ac2e02ef3
Etude de l'instabilité génomique et du statut des télomères dans le cancer du sein.
Gay‐Bellile, M. (2017) · theses.fr (ABES) · doi:10.70675/320a4136z144cz4b1ezb9e2z5cc2471afa58
Modulation du phénotype dans les cellules HMEC
Khalil, A. A. (2017) · theses.fr (ABES) · doi:10.70675/6da7ee1cze71bz40d8zaed3z03b1f1954a27
Knights, C. D., & Pestell, R. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-337-0_1
Metadata
- Authors
- Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., Miranda, M., Krig, S., Garbe, J., Stampfer, M., Yaswen, P., Gray, J. W., & Lockett, S. J.
- Affiliations
- University of California, San Francisco (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Gray, Joe W
- Venue
- Nature Genetics
- Published
- 2004-08-08
- Volume
- 36
- Issue
- 9
- Pages
- 984-988
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2053300345
- Semantic Scholar
- 005930a6472117d3d08d09415087ec01d5c8ecb1
- Cited by
- 361
- References
- 30
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 6 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 8 · 2019: 8 · 2018: 17 · 2017: 15 · 2016: 19 · 2015: 19 · 2014: 14 · 2013: 24 · 2012: 24
- FWCI
- 15.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Energy
- U.S. Department of Health and Human Services
- Avon Foundation for Women
- Universiteit Leiden
- National Institutes of Health
- National Cancer Institute (R01CA101359, R01CA090421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- genomic instability, telomere crisis, breast cancer progression, ductal carcinoma in situ, usual ductal hyperplasia, mammary epithelial cells, ZNF217, cell immortalization, fluorescence in situ hybridization
- MeSH terms
- Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Humans, Hyperplasia, Tumor Cells, Cultured, Ultrasonography, Telomere, In Situ Hybridization, Carcinoma, Ductal, Breast, Disease Progression, Chromosomal Instability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.